Statistics for Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study
Total visits
| views | |
|---|---|
| Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study | 11 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| Influenza Resp Viruses - 2024 - Monge - Effectiveness of XBB 1 5 Monovalent COVID‐19 Vaccines During a Period of XBB 1 5.pdf | 24 |
Top country views
| views | |
|---|---|
| Portugal | 11 |
Top city views
| views | |
|---|---|
| Braga | 11 |